Issues associated with upscaling exosome production for therapeutic use may be overcome through utilizing artificial exosomes. Cell-derived mimetic nanovesicles (M-NVs) are a potentially...
Read More »
The era of using extracellular vesicles (EVs) and exosomes for regenerative medicine applications in the clinic is here. The team at Capricor Therapeutics, Inc. utilized a cardiosphere-derived stem-like cell culturing process to manufacture secreted EVs present in conditioned medium for ...
Read More »
Capricor Therapeutics, Inc. a clinical-stage biotechnology company developing biological therapies for cardiac and other serious medical conditions, today announced that the U.S. Department of Defense (DoD) has awarded the company a grant1 in the amount of approximately $2.4 million to ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
